10times
06 - 08 Oct 2020Ended

Immuno- Oncology Virtual Summit

About 27Sessions 31SpeakersExhibitorsReviewsPhotos

Timings

09:00 AM - 06:00 PM
Not Verified

Official Links

Estimated Turnout

100 - 500
Delegates
Based on previous editions

Editions

06 - 08 Oct 2020
+1 more editions

Frequency

Quarterly
Next edition likely in Jan 2021
Claim event to edit details

Over the past 8 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing .. Read more comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI's IO Summit provides.

Filter By
Tue, 06 Oct 09:00 AM - 09:20 AM Session
Immunotherapy Biomarkers – Blood and Tumor State of the Art
Adil Daud
Adil Daud Director
Tue, 06 Oct 09:20 AM - 09:40 AM Session
Identifying I-O Response-Predictive Markers via Tumor Size Dynamics
Dean Bottino
Dean Bottino Sr. Scientific Director
Tue, 06 Oct 09:40 AM - 10:00 AM Session
Guiding the Personalization of Immunotherapy in Cancer through Biology and Biomarkers – Predicting Response and Toxicity
Justin M. Balko
Justin M. Balko Associate Professor
Tue, 06 Oct 10:20 AM - 10:40 AM Break
Session Break
Tue, 06 Oct 10:40 AM - 11:00 AM Session
Multiparametric Immune Monitoring of Multi-Center I/O Clinical Trials: Uncovering Hidden Correlates of Response
Steven P. Fling
Steven P. Fling Lab Director
Tue, 06 Oct 11:00 AM - 11:20 AM Session
Tumor-Derived Exosomes Emerge as Key Components of Precision Oncology
Theresa Whiteside
Theresa Whiteside Professor
Tue, 06 Oct 12:40 PM - 01:00 PM Session
The Influence of the Cancer Genome on Tumor Immunity
Nadeem Riaz
Nadeem Riaz Associate Director
Tue, 06 Oct 01:00 PM - 01:20 PM Session
Multi-Modality Approach to Immunotherapy Response and Resistance
Genevieve Boland
Genevieve Boland Assistant Professor
Tue, 06 Oct 02:00 PM - 02:20 PM Session
Replication Stress Response Defects Predict Response to Immune Checkpoint Blockade in Non-Hypermutated Cancers
Shiaw-Yih (Phoebus) Lin
Shiaw-Yih (Phoebus) Lin Professor, Systems Biology, MD Anderson Cance..
Tue, 06 Oct 02:20 PM - 04:30 PM Session
Distinct Immune Signatures in Mesothelioma: Implications in Therapeutic Strategies
Cara Haymaker
Cara Haymaker Director
Wed, 07 Oct 09:00 AM - 09:20 AM Session
PD-1 Antibodies Either as Monotherapy or Precision Medicine Informed Combinations Are Transforming Cancer Care
Roy Baynes
Roy Baynes Senior VP and Head, Global Clinical Developme..
Wed, 07 Oct 09:20 AM - 09:40 AM Session
Independent Contributions Account for Clinical Activity of PD-1 Checkpoint Inhibitor Combination Therapies
Emmett Schmidt
Emmett Schmidt Distinguished Scientist & Executive Director
Wed, 07 Oct 09:40 AM - 10:00 AM Session
Long-Term Outcomes and Responses to Retreatment in Melanoma Patients Treated with PD-1 Blockade
Allison Betof Warner
Allison Betof Warner Assistant Attending Physician
Wed, 07 Oct 10:20 AM - 10:40 AM Break
Session Break - View Our Virtual Exhibit Hall
Wed, 07 Oct 10:40 AM - 11:00 AM Session
Humanized Mouse Models as a Tool to Evaluate IO Therapeutics
Virna Cortez-Retamozo
Virna Cortez-Retamozo Lab Head
Wed, 07 Oct 11:00 AM - 11:20 AM Session
Translatability of Preclinical Models in Immuno-Oncology Drug Discovery
Mithun Khattar
Mithun Khattar Scientist II, Immuno-Oncology Lead
Wed, 07 Oct 11:20 AM - 11:40 AM Session
Efficacy Testing and Mechanistic Studies in Patient-Derived Microtumor/Immune Cell Models
Christoph Sachse
Christoph Sachse Site Head, NMI TT Pharmaservices
Wed, 07 Oct 11:40 AM - 12:15 PM Session
Preclinical Identification and Validation of Immuno-Oncology Targets
Marcus Bosenberg
Marcus Bosenberg Interim Director
Wed, 07 Oct 01:00 PM - 01:20 PM Session
Deciphering the Function of B Cells in Human Cancer
Tullia C. Bruno
Tullia C. Bruno Assistant Professor
Wed, 07 Oct 01:20 PM - 01:40 PM Session
Understanding Resistance to Develop Next-Generation CAR T Cell Immunotherapies
Marco Ruella
Marco Ruella Assistant Professor
Thu, 08 Oct 09:00 AM - 09:20 AM Session
Th17-Inducing Vaccines for the Treatment of Cancer
Keith Knutson
Keith Knutson Director
Thu, 08 Oct 09:20 AM - 09:40 AM Session
Use of Enveloped Virus-Like Particles (eVLPs) in ImmunoOncology
David Anderson
David Anderson CSO, Research & Development, VBI Vaccines, In..
Thu, 08 Oct 09:40 AM - 10:00 AM Session
Can Vaccination Overcome Immune Ignorance and Segregation within the Tumor Microenvironment?
Robert Pierce
Robert Pierce CSO, Sensei Biotherapeutics
Thu, 08 Oct 10:40 AM - 11:00 AM Session
Clinical Development of Monoclonal Antibodies Targeting Tumor Neoepitopes
Philip Arlen
Philip Arlen President & CEO
Thu, 08 Oct 11:00 AM - 11:20 AM Session
Updated Approaches for Neoantigen Vaccination for Oncology
David A. Reardon
David A. Reardon Professor, Medicine, Harvard Medical School; ..
Thu, 08 Oct 11:20 AM - 11:40 AM Session
Bringing Personalized Cancer Vaccines to the Patients: Update on Clinical Data, Challenges and Learnings from the VB N-01 Clinical Study
Agnete Fredriksen
Agnete Fredriksen PhD, CSO, Vaccibody
Thu, 08 Oct 11:40 AM - 12:15 PM Session
Personalized Treatments for Cancer – At the Intersection of Precision Medicine and Immunotherapy
Niranjan Y. Sardesai
Niranjan Y. Sardesai Co-Founder, President & CEO, Geneos Therapeut..
Speaker
Marcus Bosenberg

Marcus Bosenberg

Interim Director
Speaker
Roy Baynes

Roy Baynes

Senior VP and Head, Global Clinical Development
Speaker
Dean Bottino

Dean Bottino

Sr. Scientific Director
Speaker
Virna Cortez-Retamozo

Virna Cortez-Retamozo

Lab Head
Visitor/General
1199 USD Early Bird Registration for Commercial (Till 28th Aug'2020)
599 USD Early Bird Registration for Academic, Government, Hospital Affiliated (Till 28th Aug'2020)
1499 USD Standard Registration for Commercial (After 28th Aug'2020)
799 USD Standard Registration for Academic, Government, Hospital Affiliated (After 28th Aug'2020)
  • Followers
  • [ Users who have shown interest for this Event ]
Prerna Saini

Prerna Saini

Doctor at Med Episodes

Kiev, Ukraine
  • Share your Experience
  • Organizer
Logo Follow Company

Cambridge Healthtech Institute

USA 201 Total Events / 64 Upcoming Events

More Events From The Organizer